Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Equity Average: 2011-2024

Historic Equity Average for OptimizeRx (OPRX) over the last 14 years, with FY2024 value amounting to $121.8 million.

  • OptimizeRx's Equity Average rose 257.6% to $120.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.8 million, marking a year-over-year increase of 257.6%. This contributed to the annual value of $121.8 million for FY2024, which is 360.68% down from last year.
  • OptimizeRx's Equity Average amounted to $121.8 million in FY2024, which was down 360.68% from $126.3 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Equity Average ranged from a high of $128.7 million in FY2022 and a low of $47.4 million during FY2020
  • Moreover, its 5-year median value for Equity Average was $121.8 million (2024), whereas its average is $103.0 million.
  • Its Equity Average has fluctuated over the past 5 years, first soared by 9122.83% in 2021, then plummeted by 360.68% in 2024.
  • OptimizeRx's Equity Average (Annual) stood at $47.4 million in 2020, then soared by 91.23% to $90.7 million in 2021, then soared by 41.98% to $128.7 million in 2022, then fell by 1.87% to $126.3 million in 2023, then fell by 3.61% to $121.8 million in 2024.
  • Its Equity Average stands at $121.8 million for FY2024, versus $126.3 million for FY2023 and $128.7 million for FY2022.